Gemcitabine plus oxaliplatin for patients with advanced hepatocellular carcinoma using two different schedules.
about
Multicenter phase II study of gemcitabine and oxaliplatin (GEMOX) as second-line chemotherapy in colorectal cancer patients pretreated with 5-fluorouracil plus irinotecan.Salvage chemotherapy with gemcitabine and oxaliplatin in heavily pretreated patients with metastatic breast cancer: a multicenter phase II study.Gemcitabine and oxaliplatin as second-line treatment in patients with hepatocellular carcinoma pre-treated with sorafenib.Gemcitabine and cisplatin-based combination chemotherapy in advanced hepatocellular carcinoma: An Indian experienceFeasibility of gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma patients with Child-Pugh B cirrhosis.Gemcitabine and oxaliplatin chemotherapy for advanced hepatocellular carcinoma after failure of anti-angiogenic therapies.Efficacy and safety of sorafenib in combination with gemcitabine in patients with advanced hepatocellular carcinoma: a multicenter, open-label, single-arm phase II study.Downstaging and resection after neoadjuvant therapy for fibrolamellar hepatocellular carcinoma.Anti-hepatocarcinoma activity of TT-1, an analog of melittin, combined with interferon-α via promoting the interaction of NKG2D and MICAMechanisms of resistance to sorafenib and the corresponding strategies in hepatocellular carcinomaEarly development of sunitinib in hepatocellular carcinoma.Systemic therapy for advanced hepatocellular carcinoma: past, present, and future.Gemox: a widely useful therapy against solid tumors-review and personal experience.Emerging strategies in the treatment of advanced hepatocellular carcinoma: the role of targeted therapies.Secretory clusterin contributes to oxaliplatin resistance by activating Akt pathway in hepatocellular carcinoma.Prolonged Complete Response after GEMOX Chemotherapy in a Patient with Advanced Fibrolamellar Hepatocellular Carcinoma.Neoadjuvant sorafenib combined with gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma.Feasibility of oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX-4) in cirrhotic or liver transplant patients: experience in a cohort of advanced hepatocellular carcinoma patients.Optimal therapy for patients with hepatocellular carcinoma and resistance or intolerance to sorafenib: challenges and solutions.
P2860
Q33371015-AA7F5A58-37A2-4A94-B48F-32A39A19CA0FQ33373017-683EE5FA-1C0F-4FA6-B5AD-34F33E52C305Q33400294-F5FD6FEC-8605-4CDA-8631-859443199FD2Q33402113-3F27DAA4-0512-4778-AA5E-886196A4516FQ33403870-12BFAE1F-CD22-4516-BC26-E99C9589DE32Q33414726-E4F4E3E9-6E66-47AF-8A85-67CB3D75EF3CQ33415172-33B72D3C-F036-4D52-AE40-415C26A962BDQ33814048-E9B816A7-68DF-42CD-A055-D44E59F39E1BQ33825926-97A35152-402B-4A15-8B98-6454897A7A1DQ37049104-EDC47034-2C72-4EBB-ACCE-D3347C8087A3Q37357314-398373CB-0A41-47B4-B35D-880C0C23B1B8Q37734197-E0B99A6E-48F8-43B5-BA22-D07919B28D7CQ37814700-29CCE73D-CAFD-40E1-881E-61784492B886Q37828640-93B3C20D-5E91-4ADA-9F06-EE4982300603Q39218247-9EE02D25-C3DD-4044-96C6-1AA6B7B320D4Q41786165-CF954748-1A25-4CF2-B36A-F9FE25CD5650Q41808165-B5320405-21B3-480A-93C8-12320A4CD971Q44172632-9354FD5B-9DCE-4FC6-82DE-C72C20694808Q47108754-3D75FEBE-F9D6-41FB-B7E6-730FFFDD2232
P2860
Gemcitabine plus oxaliplatin for patients with advanced hepatocellular carcinoma using two different schedules.
description
2003 nî lūn-bûn
@nan
2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Gemcitabine plus oxaliplatin f ...... using two different schedules.
@ast
Gemcitabine plus oxaliplatin f ...... using two different schedules.
@en
type
label
Gemcitabine plus oxaliplatin f ...... using two different schedules.
@ast
Gemcitabine plus oxaliplatin f ...... using two different schedules.
@en
prefLabel
Gemcitabine plus oxaliplatin f ...... using two different schedules.
@ast
Gemcitabine plus oxaliplatin f ...... using two different schedules.
@en
P2093
P2860
P50
P356
P1433
P1476
Gemcitabine plus oxaliplatin f ...... using two different schedules.
@en
P2093
Jean-Marie Tigaud
Lamia Golli
Laureut Hannoun
Luminita Bonyhay
Marie Anna Delgado
Michel Ducreux
Thierry de Baere
Touraj Mansourbakht
P2860
P304
P356
10.1002/CNCR.11869
P407
P577
2003-12-01T00:00:00Z